Literature DB >> 24997583

Long-term prognosis of nerve palsy after total hip arthroplasty: results of two-year-follow-ups and long-term results after a mean time of 8 years.

B Zappe1, P M Glauser, M Majewski, H R Stöckli, P E Ochsner.   

Abstract

INTRODUCTION: Nerve damage is a rare but serious complication after THA. There exist only little data about the outcome of these patients particularly regarding the long-term results later than 2 years postoperatively. Aim of this study is to answer the following questions: Is the recovery to be expected for light nerve lesions different from the severe ones? Is there a possibility of nerve recovery more than 2 years after THA? Is the potential of nerve recovery depending on the affected nerve?
MATERIALS AND METHODS: This study investigates 2,255 primary THA as well as revision surgeries performed from 1988 to 2003 relating to iatrogenic nerve lesion. We classified the nerve lesion according to the core muscle strength in severe (M0-M2) and light (M3-M4) nerve damage and differentiated between femoral, sciatic and superior gluteal nerve, according to the electromyography.
RESULTS: We found 34 cases of iatrogenic nerve damage representing an incidence of 1.5 %. 17 of 34 (50 %) patients showed a complete recovery after 2 years. Out of the remaining 17 patients, six out of seven patients with a final examination after a median time of 93 months achieved further improvement. The different nerves showed no significant different potential of recovery.
CONCLUSIONS: In contrast to the literature, an improvement beyond the limit of 2 years is probable and independent of the nerve affected.

Entities:  

Mesh:

Year:  2014        PMID: 24997583     DOI: 10.1007/s00402-014-2038-0

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  8 in total

Review 1.  Posterior, Lateral, and Anterior Hip Pain Due to Musculoskeletal Origin: A Narrative Literature Review of History, Physical Examination, and Diagnostic Imaging.

Authors:  Patrick J Battaglia; Kevin D'Angelo; Norman W Kettner
Journal:  J Chiropr Med       Date:  2016-10-21

2.  High-resolution metal artifact reduction MR imaging of the lumbosacral plexus in patients with metallic implants.

Authors:  Shivani Ahlawat; Steven E Stern; Allan J Belzberg; Jan Fritz
Journal:  Skeletal Radiol       Date:  2017-03-30       Impact factor: 2.199

3.  Common peroneal nerve palsy after primary total hip arthroplasty.

Authors:  Vlad Alexandru Georgeanu; Octav Marius Russu; Bogdan Obada; Madalina-Gabriela Iliescu; Marius Nicolae Popescu; Dan Marcel Iliescu; Vlad Predescu
Journal:  Int Orthop       Date:  2022-06-17       Impact factor: 3.479

Review 4.  Sciatic Nerve Palsy following Total Hip Replacement: Are Patients Personal Characteristics More Important than Limb Lengthening? A Systematic Review.

Authors:  Marcello De Fine; Matteo Romagnoli; Stefano Zaffagnini; Giovanni Pignatti
Journal:  Biomed Res Int       Date:  2017-11-15       Impact factor: 3.411

5.  Do Acetabular Buttress Augment Pose Risk to the Superior Gluteal Nerve? A Cadaveric Study.

Authors:  Austin A Cole; Parker R Zimmerman; Michael S Sridhar
Journal:  Arthroplast Today       Date:  2020-12-21

6.  The morphometrical and topographical evaluation of the superior gluteal nerve in the prenatal period.

Authors:  Alicja Kędzia; Krzysztof Dudek; Marcin Ziajkiewicz; Michal Wolanczyk; Anna Seredyn; Wojciech Derkowski; Zygmunt Antoni Domagala
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

7.  Risk Factors for the Development of Nerve Palsy Following Primary Total Hip Arthroplasty.

Authors:  Shunsuke Kawano; Motoki Sonohata; Masaru Kitajima; Masaaki Mawatari
Journal:  Open Orthop J       Date:  2018-04-23

8.  A systematic review and meta-analysis of the hip capsule innervation and its clinical implications.

Authors:  Joanna Tomlinson; Benjamin Ondruschka; Torsten Prietzel; Johann Zwirner; Niels Hammer
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.